pubmed-article:21554143 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0016658 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0029456 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C1556094 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0022417 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0102118 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0814861 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C1706309 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0044410 | lld:lifeskim |
pubmed-article:21554143 | lifeskim:mentions | umls-concept:C0332167 | lld:lifeskim |
pubmed-article:21554143 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:21554143 | pubmed:dateCreated | 2011-5-17 | lld:pubmed |
pubmed-article:21554143 | pubmed:abstractText | The authors conducted a randomized controlled trial to clarify the efficacy and safety of alendronate plus alfacalcidol versus alendronate alone in a clinical setting. | lld:pubmed |
pubmed-article:21554143 | pubmed:language | eng | lld:pubmed |
pubmed-article:21554143 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21554143 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:21554143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21554143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21554143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21554143 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21554143 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21554143 | pubmed:month | Jun | lld:pubmed |
pubmed-article:21554143 | pubmed:issn | 1473-4877 | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:NakamuraToshi... | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:HosoiTakayuki... | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:OhashiYasuoY | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:FukunagaMasao... | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:OhtaHiroakiH | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:ShirakiMasata... | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:OrimoHajimeH | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:MiyakawaNobua... | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:KurodaTatsuhi... | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:UemuraYukariY | lld:pubmed |
pubmed-article:21554143 | pubmed:author | pubmed-author:A-TOP... | lld:pubmed |
pubmed-article:21554143 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21554143 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:21554143 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21554143 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21554143 | pubmed:pagination | 1273-84 | lld:pubmed |
pubmed-article:21554143 | pubmed:meshHeading | pubmed-meshheading:21554143... | lld:pubmed |
pubmed-article:21554143 | pubmed:meshHeading | pubmed-meshheading:21554143... | lld:pubmed |
pubmed-article:21554143 | pubmed:meshHeading | pubmed-meshheading:21554143... | lld:pubmed |
pubmed-article:21554143 | pubmed:meshHeading | pubmed-meshheading:21554143... | lld:pubmed |
pubmed-article:21554143 | pubmed:meshHeading | pubmed-meshheading:21554143... | lld:pubmed |
pubmed-article:21554143 | pubmed:meshHeading | pubmed-meshheading:21554143... | lld:pubmed |
pubmed-article:21554143 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21554143 | pubmed:articleTitle | Effects of alendronate plus alfacalcidol in osteoporosis patients with a high risk of fracture: the Japanese Osteoporosis Intervention Trial (JOINT) - 02. | lld:pubmed |
pubmed-article:21554143 | pubmed:affiliation | Health Science University, Yamanashi, Japan. | lld:pubmed |
pubmed-article:21554143 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21554143 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:21554143 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |